PointState Capital’s Momenta Pharmaceuticals MNTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
– Sell
-24,834
Closed -$566K – 153
2015
Q2
$566K Buy
+24,834
New +$495K 0.01% 143
2014
Q1
– Sell
-350,000
Closed -$6.19M – 164
2013
Q4
$6.19M Buy
+350,000
New +$5.88M 0.08% 108

Other funds holding MNTA

PointState Capital's MNTA Position: Q3 2015 in Review

PointState Capital sold out of Momenta Pharmaceuticals (MNTA) in Q3 2015, closing a stake of 24,834 shares — an estimated $566K sold.

PointState Capital first reported a position in MNTA in Q4 2013 and held it in 2 quarters. The position peaked at $6.19M in Q4 2013. 156 funds tracked by Wall St. Rank hold MNTA as of Q3 2015.

  • PointState Capital reported no remaining Momenta Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • PointState Capital sold 24,834 Momenta Pharmaceuticals shares in Q3 2015, an estimated $566K.
  • PointState Capital first reported a position in Momenta Pharmaceuticals in Q4 2013 and held it in 2 quarters.
  • PointState Capital's Momenta Pharmaceuticals position peaked at $6.19M in Q4 2013.
  • 156 funds tracked by Wall St. Rank held Momenta Pharmaceuticals as of Q3 2015.

Based on PointState Capital's 13F filing for Q3 2015, filed 16 Nov 2015.